Table 1 Patient characteristics
Patient Characteristic, N = 30 | |
|---|---|
On Study Age (years), median | 63.5 (32–79) |
Gender, N (%) | |
Female | 13 (43) |
Male | 17 (57) |
Race, N (%) | |
Black, | 2 (7) |
White | 28 (93) |
Ethnicity, N (%) | |
Hispanic or Latino | 1 (3) |
Not Hispanic or Latino | 27 (90) |
Unknown | 2 (7) |
Location of Primary Tumor, N (%) | |
Head | 15 (50) |
Body/tail | 1 (3) |
Body | 5 (16) |
Tail | 8 (27) |
Uncinated | 1 (3) |
Differentiation, N (%) | |
Poorly differentiated | 14 (47) |
Moderate differentiated | 11 (37) |
Well-differentiated | 1 (3) |
Unknown | 4 (13) |
Stage at Diagnosis, N (%) | |
IB-IIB | 12 (40) |
III | 3 (10) |
IV | 15 (50) |
Surgical Resection, N (%) | |
N | 19 (63) |
Y | 11 (37) |
ECOG 0, N (%) | 8 (27) |
Lines of Chemo, N (%) | |
1 | 11 (37) |
2 | 17 (57) |
3 | 2 (7) |
Metastatic site at enrollment, N (%) | |
Liver | 26 (87) |
Lung | 15 (50) |
Peritoneum | 13 (40) |
Lymph nodes | 11 (37) |
Other (adrenal gland, bone) | 3 (10) |
CA 19-9 secretors, N (%) | 27 (90) |
